Pazopanib Tablet
Product Images NDC 51407-872

This is a description for a medication with the NDC code 51407-872-12, which contains tablets of pazopanib hydrochloride. Each film-coated tablet contains 216.7 mg of pazopanib hydrochloride, equivalent to 200 mg of pazopanib free base. The pharmacist is instructed to dispense the Medication Guide to each patient. The medication guide can be printed from the link provided. The dosage information is available in the accompanying Prescribing Information. It is advised not to use the medication if the seal on the bottle is broken or missing. The medication should be stored at a temperature range of 20° - 25°C (68° - 77°F) with excursions permitted to 15° - 30°C (59° - 86°F) as per USP Controlled Room Temperature guidelines. This medication is distributed by GSMS, Incorporated in Camarillo, CA.*

This text appears to be related to a medical study or clinical trial evaluating the progression or development of a condition under the influence of a drug treatment versus a placebo. The hazard ratio is reported as 0.46 with a corresponding 95% confidence interval from 0.34 to 0.62. The p-value is noted to be less than 0.061, indicating potential statistical significance. The study duration seems to be measured in months.*

This is a summary of a clinical study comparing the progression-free survival of patients under treatment with Pazopanib (median 4.6 months) versus a placebo (median 1.6 months). The hazard ratio was 0.35 with a 95% confidence interval of (0.26, 0.48) and a significant p-value of less than 0.001. This information suggests that Pazopanib treatment is associated with a significantly longer progression-free survival compared to the placebo.*